nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenobarbital—GRIK2—Parkinson's disease	0.41	0.539	CbGaD
Methylphenobarbital—CHRNA4—Parkinson's disease	0.35	0.461	CbGaD
Methylphenobarbital—CHRNA4—superior cervical ganglion—Parkinson's disease	0.0098	0.0957	CbGeAlD
Methylphenobarbital—CHRNA4—adrenal medulla—Parkinson's disease	0.00804	0.0785	CbGeAlD
Methylphenobarbital—GRIK2—cerebellar cortex—Parkinson's disease	0.00686	0.067	CbGeAlD
Methylphenobarbital—GRIK2—telencephalic ventricle—Parkinson's disease	0.00399	0.039	CbGeAlD
Methylphenobarbital—CHRNA4—autonomic nervous system—Parkinson's disease	0.0036	0.0351	CbGeAlD
Methylphenobarbital—CHRNA4—telencephalic ventricle—Parkinson's disease	0.00321	0.0313	CbGeAlD
Methylphenobarbital—CHRNA4—peripheral nervous system—Parkinson's disease	0.00259	0.0253	CbGeAlD
Methylphenobarbital—GRIK2—nerve—Parkinson's disease	0.00252	0.0246	CbGeAlD
Methylphenobarbital—GRIA2—hindbrain—Parkinson's disease	0.00209	0.0204	CbGeAlD
Methylphenobarbital—CHRNA4—nerve—Parkinson's disease	0.00202	0.0198	CbGeAlD
Methylphenobarbital—GABRA6—hindbrain—Parkinson's disease	0.00202	0.0197	CbGeAlD
Methylphenobarbital—GRIK2—hindbrain—Parkinson's disease	0.00188	0.0184	CbGeAlD
Methylphenobarbital—CHRNA4—hindbrain—Parkinson's disease	0.00151	0.0148	CbGeAlD
Methylphenobarbital—GABRA2—hindbrain—Parkinson's disease	0.00136	0.0132	CbGeAlD
Methylphenobarbital—GABRA1—hindbrain—Parkinson's disease	0.00131	0.0128	CbGeAlD
Methylphenobarbital—GRIA2—embryo—Parkinson's disease	0.0013	0.0127	CbGeAlD
Methylphenobarbital—GRIA2—brainstem—Parkinson's disease	0.0012	0.0117	CbGeAlD
Methylphenobarbital—GABRA6—brainstem—Parkinson's disease	0.00116	0.0113	CbGeAlD
Methylphenobarbital—GRIA2—forebrain—Parkinson's disease	0.00115	0.0113	CbGeAlD
Methylphenobarbital—GABRA5—forebrain—Parkinson's disease	0.00108	0.0106	CbGeAlD
Methylphenobarbital—GRIK2—brainstem—Parkinson's disease	0.00108	0.0106	CbGeAlD
Methylphenobarbital—CHRFAM7A—forebrain—Parkinson's disease	0.00105	0.0103	CbGeAlD
Methylphenobarbital—GRIK2—forebrain—Parkinson's disease	0.00104	0.0102	CbGeAlD
Methylphenobarbital—Hexobarbital—GRIK2—Parkinson's disease	0.00103	0.16	CrCbGaD
Methylphenobarbital—GABRA4—forebrain—Parkinson's disease	0.000981	0.00958	CbGeAlD
Methylphenobarbital—Hexobarbital—CHRNA4—Parkinson's disease	0.000885	0.137	CrCbGaD
Methylphenobarbital—CHRNA4—brainstem—Parkinson's disease	0.000868	0.00848	CbGeAlD
Methylphenobarbital—CHRNA7—forebrain—Parkinson's disease	0.000849	0.0083	CbGeAlD
Methylphenobarbital—CHRNA4—forebrain—Parkinson's disease	0.000838	0.00818	CbGeAlD
Methylphenobarbital—GABRA2—brainstem—Parkinson's disease	0.000777	0.00759	CbGeAlD
Methylphenobarbital—GRIA2—midbrain—Parkinson's disease	0.000762	0.00744	CbGeAlD
Methylphenobarbital—GRIK2—medulla oblongata—Parkinson's disease	0.000753	0.00736	CbGeAlD
Methylphenobarbital—GABRA1—brainstem—Parkinson's disease	0.000751	0.00734	CbGeAlD
Methylphenobarbital—GABRA2—forebrain—Parkinson's disease	0.00075	0.00733	CbGeAlD
Methylphenobarbital—GRIA2—spinal cord—Parkinson's disease	0.000743	0.00726	CbGeAlD
Methylphenobarbital—GABRA1—forebrain—Parkinson's disease	0.000725	0.00708	CbGeAlD
Methylphenobarbital—CHRNA7—cardiovascular system—Parkinson's disease	0.000718	0.00701	CbGeAlD
Methylphenobarbital—CHRNA4—cardiovascular system—Parkinson's disease	0.000708	0.00692	CbGeAlD
Methylphenobarbital—GRIK2—midbrain—Parkinson's disease	0.000688	0.00672	CbGeAlD
Methylphenobarbital—GRIK2—spinal cord—Parkinson's disease	0.000672	0.00656	CbGeAlD
Methylphenobarbital—GRIA2—head—Parkinson's disease	0.000661	0.00645	CbGeAlD
Methylphenobarbital—Pethidine—GRIN2B—Parkinson's disease	0.000657	0.102	CrCbGaD
Methylphenobarbital—GABRA6—head—Parkinson's disease	0.000638	0.00624	CbGeAlD
Methylphenobarbital—GRIA2—nervous system—Parkinson's disease	0.000626	0.00612	CbGeAlD
Methylphenobarbital—GABRA5—head—Parkinson's disease	0.000619	0.00605	CbGeAlD
Methylphenobarbital—GABRA6—nervous system—Parkinson's disease	0.000605	0.00591	CbGeAlD
Methylphenobarbital—GRIA2—central nervous system—Parkinson's disease	0.000603	0.00589	CbGeAlD
Methylphenobarbital—CHRFAM7A—head—Parkinson's disease	0.000602	0.00588	CbGeAlD
Methylphenobarbital—Primidone—GRIK2—Parkinson's disease	0.000599	0.0928	CrCbGaD
Methylphenobarbital—GRIK2—head—Parkinson's disease	0.000597	0.00583	CbGeAlD
Methylphenobarbital—GRIA2—cerebellum—Parkinson's disease	0.00059	0.00576	CbGeAlD
Methylphenobarbital—GABRA5—nervous system—Parkinson's disease	0.000587	0.00574	CbGeAlD
Methylphenobarbital—GABRA6—central nervous system—Parkinson's disease	0.000583	0.00569	CbGeAlD
Methylphenobarbital—GABRA3—head—Parkinson's disease	0.000577	0.00563	CbGeAlD
Methylphenobarbital—CHRFAM7A—nervous system—Parkinson's disease	0.000571	0.00558	CbGeAlD
Methylphenobarbital—GABRA6—cerebellum—Parkinson's disease	0.00057	0.00556	CbGeAlD
Methylphenobarbital—GRIK2—nervous system—Parkinson's disease	0.000566	0.00553	CbGeAlD
Methylphenobarbital—GABRA5—central nervous system—Parkinson's disease	0.000565	0.00552	CbGeAlD
Methylphenobarbital—GABRA4—head—Parkinson's disease	0.000562	0.00549	CbGeAlD
Methylphenobarbital—CHRNA4—midbrain—Parkinson's disease	0.000553	0.0054	CbGeAlD
Methylphenobarbital—CHRFAM7A—central nervous system—Parkinson's disease	0.00055	0.00537	CbGeAlD
Methylphenobarbital—GABRA3—nervous system—Parkinson's disease	0.000547	0.00534	CbGeAlD
Methylphenobarbital—GRIK2—central nervous system—Parkinson's disease	0.000545	0.00532	CbGeAlD
Methylphenobarbital—CHRNA4—spinal cord—Parkinson's disease	0.00054	0.00527	CbGeAlD
Methylphenobarbital—GABRA4—nervous system—Parkinson's disease	0.000533	0.0052	CbGeAlD
Methylphenobarbital—GRIK2—cerebellum—Parkinson's disease	0.000533	0.0052	CbGeAlD
Methylphenobarbital—GABRA3—central nervous system—Parkinson's disease	0.000526	0.00514	CbGeAlD
Methylphenobarbital—GABRA1—medulla oblongata—Parkinson's disease	0.000524	0.00511	CbGeAlD
Methylphenobarbital—GABRA4—central nervous system—Parkinson's disease	0.000513	0.00501	CbGeAlD
Methylphenobarbital—Primidone—CHRNA4—Parkinson's disease	0.000513	0.0794	CrCbGaD
Methylphenobarbital—GABRA4—cerebellum—Parkinson's disease	0.000501	0.0049	CbGeAlD
Methylphenobarbital—CHRNA7—head—Parkinson's disease	0.000486	0.00475	CbGeAlD
Methylphenobarbital—CHRNA4—head—Parkinson's disease	0.00048	0.00469	CbGeAlD
Methylphenobarbital—GRIA2—brain—Parkinson's disease	0.000479	0.00468	CbGeAlD
Methylphenobarbital—GABRA1—midbrain—Parkinson's disease	0.000479	0.00467	CbGeAlD
Methylphenobarbital—GABRA1—spinal cord—Parkinson's disease	0.000467	0.00456	CbGeAlD
Methylphenobarbital—GABRA6—brain—Parkinson's disease	0.000463	0.00452	CbGeAlD
Methylphenobarbital—CHRNA7—nervous system—Parkinson's disease	0.000461	0.0045	CbGeAlD
Methylphenobarbital—CHRNA4—nervous system—Parkinson's disease	0.000455	0.00444	CbGeAlD
Methylphenobarbital—GABRA5—brain—Parkinson's disease	0.000449	0.00438	CbGeAlD
Methylphenobarbital—CHRNA7—central nervous system—Parkinson's disease	0.000444	0.00434	CbGeAlD
Methylphenobarbital—CHRNA4—central nervous system—Parkinson's disease	0.000438	0.00428	CbGeAlD
Methylphenobarbital—CHRFAM7A—brain—Parkinson's disease	0.000436	0.00426	CbGeAlD
Methylphenobarbital—GRIK2—brain—Parkinson's disease	0.000433	0.00423	CbGeAlD
Methylphenobarbital—GABRA2—head—Parkinson's disease	0.000429	0.00419	CbGeAlD
Methylphenobarbital—Hexobarbital—CYP2E1—Parkinson's disease	0.000429	0.0665	CrCbGaD
Methylphenobarbital—CHRNA4—cerebellum—Parkinson's disease	0.000428	0.00418	CbGeAlD
Methylphenobarbital—GABRA3—brain—Parkinson's disease	0.000418	0.00408	CbGeAlD
Methylphenobarbital—GABRA1—head—Parkinson's disease	0.000415	0.00405	CbGeAlD
Methylphenobarbital—GABRA4—brain—Parkinson's disease	0.000407	0.00398	CbGeAlD
Methylphenobarbital—GABRA2—nervous system—Parkinson's disease	0.000407	0.00398	CbGeAlD
Methylphenobarbital—GABRA1—nervous system—Parkinson's disease	0.000393	0.00384	CbGeAlD
Methylphenobarbital—GABRA2—central nervous system—Parkinson's disease	0.000392	0.00383	CbGeAlD
Methylphenobarbital—GABRA2—cerebellum—Parkinson's disease	0.000383	0.00374	CbGeAlD
Methylphenobarbital—GABRA1—central nervous system—Parkinson's disease	0.000379	0.0037	CbGeAlD
Methylphenobarbital—Phenobarbital—GRIK2—Parkinson's disease	0.000378	0.0586	CrCbGaD
Methylphenobarbital—GABRA1—cerebellum—Parkinson's disease	0.00037	0.00362	CbGeAlD
Methylphenobarbital—CYP2B6—cardiovascular system—Parkinson's disease	0.000361	0.00353	CbGeAlD
Methylphenobarbital—CHRNA7—brain—Parkinson's disease	0.000352	0.00344	CbGeAlD
Methylphenobarbital—CHRNA4—brain—Parkinson's disease	0.000348	0.0034	CbGeAlD
Methylphenobarbital—Phenobarbital—CHRNA4—Parkinson's disease	0.000324	0.0501	CrCbGaD
Methylphenobarbital—Antipyrine—CYP2E1—Parkinson's disease	0.000321	0.0498	CrCbGaD
Methylphenobarbital—GABRA2—brain—Parkinson's disease	0.000311	0.00304	CbGeAlD
Methylphenobarbital—Pethidine—SLC6A3—Parkinson's disease	0.000311	0.0481	CrCbGaD
Methylphenobarbital—GABRA1—brain—Parkinson's disease	0.000301	0.00294	CbGeAlD
Methylphenobarbital—Glutethimide—CYP2D6—Parkinson's disease	0.000282	0.0436	CrCbGaD
Methylphenobarbital—CYP2B6—head—Parkinson's disease	0.000245	0.00239	CbGeAlD
Methylphenobarbital—Antipyrine—CYP2D6—Parkinson's disease	0.000236	0.0366	CrCbGaD
Methylphenobarbital—CYP2B6—nervous system—Parkinson's disease	0.000232	0.00227	CbGeAlD
Methylphenobarbital—CYP2B6—central nervous system—Parkinson's disease	0.000223	0.00218	CbGeAlD
Methylphenobarbital—CYP2B6—brain—Parkinson's disease	0.000177	0.00173	CbGeAlD
Methylphenobarbital—Pethidine—CYP2D6—Parkinson's disease	0.000163	0.0253	CrCbGaD
Methylphenobarbital—Phenobarbital—CYP2E1—Parkinson's disease	0.000157	0.0243	CrCbGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000109	0.000828	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000109	0.000826	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000108	0.000824	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.000108	0.000824	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000108	0.000819	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—SLC18A2—Parkinson's disease	0.000107	0.000817	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—HSPA8—Parkinson's disease	0.000107	0.000817	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000107	0.000816	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000107	0.000814	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000107	0.000813	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000106	0.000809	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.000106	0.000805	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000105	0.000802	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—DLG4—Parkinson's disease	0.000104	0.00079	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000103	0.000788	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—GSTA4—Parkinson's disease	0.000102	0.000775	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000102	0.000774	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—GRIN2B—Parkinson's disease	0.000101	0.000772	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—COMT—Parkinson's disease	0.000101	0.00077	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—DLG4—Parkinson's disease	0.000101	0.000766	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—MAOA—Parkinson's disease	0.0001	0.000765	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.0001	0.000765	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—CHRNA4—Parkinson's disease	0.0001	0.000764	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—SLC6A3—Parkinson's disease	0.0001	0.000761	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—CHRNA4—Parkinson's disease	9.91e-05	0.000754	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—DLG4—Parkinson's disease	9.89e-05	0.000753	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—GRIN2B—Parkinson's disease	9.84e-05	0.000749	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—DLG4—Parkinson's disease	9.71e-05	0.000739	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—SLC6A3—Parkinson's disease	9.7e-05	0.000738	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	9.67e-05	0.000736	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	9.6e-05	0.000731	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—TH—Parkinson's disease	9.56e-05	0.000728	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	9.56e-05	0.000727	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	9.54e-05	0.000726	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	9.53e-05	0.000725	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	9.49e-05	0.000722	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	9.46e-05	0.00072	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—GRIK2—Parkinson's disease	9.46e-05	0.00072	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	9.35e-05	0.000712	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	9.33e-05	0.00071	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	9.28e-05	0.000706	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	9.28e-05	0.000706	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—COMT—Parkinson's disease	9.23e-05	0.000703	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—HSPA8—Parkinson's disease	9.2e-05	0.0007	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	9.19e-05	0.0007	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—MAOA—Parkinson's disease	9.17e-05	0.000698	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—SLC18A2—Parkinson's disease	9.16e-05	0.000697	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—COMT—Parkinson's disease	9.12e-05	0.000694	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Arachidonic acid metabolism—GPX1—Parkinson's disease	9.09e-05	0.000692	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—HSPA8—Parkinson's disease	9.09e-05	0.000692	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—MAOB—Parkinson's disease	9.08e-05	0.000691	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—MAOA—Parkinson's disease	9.05e-05	0.000689	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—CHRNA4—Parkinson's disease	8.81e-05	0.00067	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	8.78e-05	0.000668	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	8.67e-05	0.00066	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—CHRNA4—Parkinson's disease	8.65e-05	0.000658	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—DLG4—Parkinson's disease	8.64e-05	0.000657	CbGpPWpGaD
Methylphenobarbital—Phenytoin—ABCB1—Parkinson's disease	8.58e-05	0.0133	CrCbGaD
Methylphenobarbital—GABRA4—Neuronal System—DLG4—Parkinson's disease	8.53e-05	0.000649	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—COMT—Parkinson's disease	8.51e-05	0.000647	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—CHRNA4—Parkinson's disease	8.5e-05	0.000647	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—MAOA—Parkinson's disease	8.45e-05	0.000643	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—GRIN2B—Parkinson's disease	8.44e-05	0.000642	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—GRIN2B—Parkinson's disease	8.33e-05	0.000634	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—SLC6A3—Parkinson's disease	8.32e-05	0.000633	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—COMT—Parkinson's disease	8.25e-05	0.000628	CbGpPWpGaD
Methylphenobarbital—Phenobarbital—ABCB1—Parkinson's disease	8.23e-05	0.0127	CrCbGaD
Methylphenobarbital—GABRA4—Neuronal System—SLC6A3—Parkinson's disease	8.21e-05	0.000625	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—MAOA—Parkinson's disease	8.19e-05	0.000623	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—DLG4—Parkinson's disease	8.14e-05	0.000619	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—COMT—Parkinson's disease	8.1e-05	0.000616	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—HSPA8—Parkinson's disease	8.07e-05	0.000614	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	8.07e-05	0.000614	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—MAOA—Parkinson's disease	8.04e-05	0.000612	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—COMT—Parkinson's disease	7.95e-05	0.000605	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	7.95e-05	0.000605	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—HSPA8—Parkinson's disease	7.93e-05	0.000603	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	7.9e-05	0.000601	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	7.84e-05	0.000597	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—COMT—Parkinson's disease	7.82e-05	0.000595	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—HSPA8—Parkinson's disease	7.79e-05	0.000593	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	7.79e-05	0.000593	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	7.76e-05	0.000591	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	7.73e-05	0.000588	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	7.71e-05	0.000587	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—GSTA4—Parkinson's disease	7.7e-05	0.000586	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—GSTA4—Parkinson's disease	7.59e-05	0.000578	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—DLG4—Parkinson's disease	7.58e-05	0.000577	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—DLG4—Parkinson's disease	7.44e-05	0.000566	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—GRIN2B—Parkinson's disease	7.41e-05	0.000564	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—DLG4—Parkinson's disease	7.31e-05	0.000556	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—SLC6A3—Parkinson's disease	7.3e-05	0.000555	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—GRIN2B—Parkinson's disease	7.27e-05	0.000553	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—CHRNA4—Parkinson's disease	7.25e-05	0.000552	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	7.22e-05	0.00055	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—SLC6A3—Parkinson's disease	7.17e-05	0.000545	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—GRIN2B—Parkinson's disease	7.15e-05	0.000544	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—COMT—Parkinson's disease	7.07e-05	0.000538	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—SLC6A3—Parkinson's disease	7.04e-05	0.000536	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—MAOA—Parkinson's disease	7.02e-05	0.000535	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—COMT—Parkinson's disease	6.98e-05	0.000532	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—MAOA—Parkinson's disease	6.94e-05	0.000528	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	6.91e-05	0.000526	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—CASP3—Parkinson's disease	6.91e-05	0.000526	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—MAOB—Parkinson's disease	6.86e-05	0.000522	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	6.82e-05	0.000519	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—CYP2D6—Parkinson's disease	6.75e-05	0.000514	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	6.74e-05	0.000513	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	6.67e-05	0.000507	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—CYP2D6—Parkinson's disease	6.66e-05	0.000506	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—HSPA8—Parkinson's disease	6.64e-05	0.000506	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	6.62e-05	0.000504	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	6.58e-05	0.000501	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—MAPK8—Parkinson's disease	6.35e-05	0.000483	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	6.3e-05	0.000479	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	6.29e-05	0.000478	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—CP—Parkinson's disease	6.28e-05	0.000478	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—DLG4—Parkinson's disease	6.24e-05	0.000474	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—COMT—Parkinson's disease	6.21e-05	0.000472	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—CP—Parkinson's disease	6.2e-05	0.000472	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—CYP2E1—Parkinson's disease	6.17e-05	0.00047	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—MAOA—Parkinson's disease	6.16e-05	0.000469	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—COMT—Parkinson's disease	6.09e-05	0.000464	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—GRIN2B—Parkinson's disease	6.09e-05	0.000464	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—CYP2E1—Parkinson's disease	6.09e-05	0.000463	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—MAOA—Parkinson's disease	6.05e-05	0.00046	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—SLC6A3—Parkinson's disease	6.01e-05	0.000457	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—COMT—Parkinson's disease	5.99e-05	0.000456	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.98e-05	0.000455	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—MAOA—Parkinson's disease	5.95e-05	0.000453	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.88e-05	0.000447	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.78e-05	0.000439	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—Parkinson's disease	5.61e-05	0.000427	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—CP—Parkinson's disease	5.51e-05	0.000419	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—CP—Parkinson's disease	5.41e-05	0.000412	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—CP—Parkinson's disease	5.31e-05	0.000404	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—COMT—Parkinson's disease	5.11e-05	0.000389	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—COMT—Parkinson's disease	5.11e-05	0.000389	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—CYP2D6—Parkinson's disease	5.1e-05	0.000388	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—GSTP1—Parkinson's disease	5.09e-05	0.000387	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—MAOA—Parkinson's disease	5.08e-05	0.000386	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—MAOA—Parkinson's disease	5.07e-05	0.000386	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—COMT—Parkinson's disease	5.04e-05	0.000384	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—CYP2D6—Parkinson's disease	5.03e-05	0.000383	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—GSTP1—Parkinson's disease	5.02e-05	0.000382	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	4.92e-05	0.000375	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—GSTM1—Parkinson's disease	4.68e-05	0.000356	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	4.66e-05	0.000355	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—GSTM1—Parkinson's disease	4.61e-05	0.000351	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	4.6e-05	0.00035	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—Parkinson's disease	4.57e-05	0.000348	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	4.53e-05	0.000345	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—Parkinson's disease	4.53e-05	0.000344	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.47e-05	0.00034	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.42e-05	0.000336	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.29e-05	0.000327	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	4.26e-05	0.000325	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.24e-05	0.000323	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.92e-05	0.000299	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	3.9e-05	0.000297	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	3.89e-05	0.000296	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—COMT—Parkinson's disease	3.86e-05	0.000294	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.85e-05	0.000293	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	3.85e-05	0.000293	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	3.84e-05	0.000292	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	3.81e-05	0.00029	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	3.79e-05	0.000289	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.79e-05	0.000288	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.77e-05	0.000287	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.73e-05	0.000284	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.7e-05	0.000282	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—Parkinson's disease	3.69e-05	0.000281	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.69e-05	0.000281	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.64e-05	0.000277	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.58e-05	0.000273	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.54e-05	0.000269	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	3.53e-05	0.000269	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	3.49e-05	0.000265	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ND3—Parkinson's disease	3.32e-05	0.000252	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—MCCC1—Parkinson's disease	3.32e-05	0.000252	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.28e-05	0.000249	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.23e-05	0.000246	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.22e-05	0.000245	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.16e-05	0.000241	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.14e-05	0.000239	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—OMD—Parkinson's disease	3.12e-05	0.000237	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—TALDO1—Parkinson's disease	3.12e-05	0.000237	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.1e-05	0.000236	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.09e-05	0.000235	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.03e-05	0.000231	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—NDUFB11—Parkinson's disease	2.96e-05	0.000225	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	2.83e-05	0.000215	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GCH1—Parkinson's disease	2.82e-05	0.000215	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.7e-05	0.000205	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	2.66e-05	0.000203	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.59e-05	0.000197	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GBA—Parkinson's disease	2.51e-05	0.000191	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—FBP1—Parkinson's disease	2.51e-05	0.000191	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—DBH—Parkinson's disease	2.51e-05	0.000191	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—MCCC1—Parkinson's disease	2.51e-05	0.000191	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ND3—Parkinson's disease	2.51e-05	0.000191	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—TALDO1—Parkinson's disease	2.36e-05	0.000179	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—OMD—Parkinson's disease	2.36e-05	0.000179	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.28e-05	0.000174	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	2.23e-05	0.00017	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GCH1—Parkinson's disease	2.13e-05	0.000162	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.92e-05	0.000146	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GBA—Parkinson's disease	1.9e-05	0.000145	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—DBH—Parkinson's disease	1.9e-05	0.000145	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—FBP1—Parkinson's disease	1.9e-05	0.000145	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—DDC—Parkinson's disease	1.84e-05	0.00014	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GSTA4—Parkinson's disease	1.74e-05	0.000133	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PLA2G6—Parkinson's disease	1.57e-05	0.000119	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—MAOB—Parkinson's disease	1.55e-05	0.000118	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—DDC—Parkinson's disease	1.39e-05	0.000106	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GSTA4—Parkinson's disease	1.32e-05	0.0001	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.3e-05	9.89e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	1.19e-05	9.02e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—MAOB—Parkinson's disease	1.17e-05	8.93e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CYP2D6—Parkinson's disease	1.15e-05	8.78e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CTGF—Parkinson's disease	1.13e-05	8.62e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.12e-05	8.5e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CYP2E1—Parkinson's disease	1.06e-05	8.03e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—NQO1—Parkinson's disease	1.04e-05	7.94e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—TH—Parkinson's disease	1.03e-05	7.83e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CYCS—Parkinson's disease	9.88e-06	7.51e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—COMT—Parkinson's disease	8.75e-06	6.66e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	8.72e-06	6.64e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GSTP1—Parkinson's disease	8.7e-06	6.62e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—MAOA—Parkinson's disease	8.68e-06	6.61e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—HMOX1—Parkinson's disease	8.58e-06	6.53e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CTGF—Parkinson's disease	8.56e-06	6.51e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ABCB1—Parkinson's disease	8.24e-06	6.27e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GSTM1—Parkinson's disease	8e-06	6.09e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	7.98e-06	6.07e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—NQO1—Parkinson's disease	7.89e-06	6e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—TH—Parkinson's disease	7.77e-06	5.91e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GPX1—Parkinson's disease	7.66e-06	5.83e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CYCS—Parkinson's disease	7.46e-06	5.68e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—MTHFR—Parkinson's disease	7.07e-06	5.38e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—COMT—Parkinson's disease	6.61e-06	5.03e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—APOE—Parkinson's disease	6.58e-06	5.01e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GSTP1—Parkinson's disease	6.58e-06	5.01e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—MAOA—Parkinson's disease	6.56e-06	4.99e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—HMOX1—Parkinson's disease	6.49e-06	4.94e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ABCB1—Parkinson's disease	6.23e-06	4.74e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GSTM1—Parkinson's disease	6.04e-06	4.6e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GPX1—Parkinson's disease	5.79e-06	4.4e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—INS—Parkinson's disease	5.62e-06	4.28e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—MTHFR—Parkinson's disease	5.34e-06	4.07e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—APOE—Parkinson's disease	4.97e-06	3.78e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—INS—Parkinson's disease	4.25e-06	3.23e-05	CbGpPWpGaD
